From June 17 to 21, 2025, the 18th International Conference on Malignant Lymphoma (ICML) will take place in Lugano. SAKK will be strongly represented at this prestigious international scientific meeting, presenting recent research findings in several contributions, including five oral presentations.

ICML is one of the world’s most important conferences in the field of malignant lymphomas and serves as a key platform for the exchange of cutting-edge knowledge among leading clinical and scientific experts.

Highlights include two oral presentations on the SAKK 38/19 study:

• Anastasios Stathis will present preliminary results on the feasibility of ctDNA- and PET-guided therapy in untreated DLBCL in the Plenary Session.
• Deborah Piffaretti will speak on clonal hematopoiesis in DLBCL.

Additional SAKK representatives will present intergroup trials:

• Paula Cramer (CLL18/MOIRAI)
• Mouhamad Khouja (TRIANGLE)
• Justin Ferdinandus (Imaging biomarkers in Hodgkin lymphoma)

For detailed planning, please see the schedule.

More information about the conference: ICML 2025.